Evidence mapPaperPMID 40929182Full record

ArticleAmerican journal of physiology. Cell physiology2025

Profibrotic immune cells and fibro-adipogenic progenitors contribute to skeletal muscle extracellular matrix remodeling and fibrosis in cancer cachexia.

Thomas D Cardaci, Arianna V Bastian, Kasie Roark, Brooke M Bullard, Mitchell M NeSmith, Christian A Unger, Robert L Price, Jason L Kubinak, E Angela Murphy, Brandon N VanderVeen

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thomas D CardaciDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.ORCID 0000-0002-4339-819X
Arianna V BastianDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
Kasie RoarkDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
Brooke M BullardDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.ORCID 0000-0003-0923-9950
Mitchell M NeSmithDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
Christian A UngerDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.ORCID 0000-0001-9776-4688
Robert L PriceDepartment of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
Jason L KubinakDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
E Angela MurphyDepartment of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina, United States.ORCID 0000-0002-4803-5822
Brandon N VanderVeenDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.ORCID 0000-0002-4535-0544

Funding

A Transdisciplinary Approach to Investigating Metabolic Dysregulation in Obese Parent and Child Dyads and Risk of Colorectal CancerU01CA272977 · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · 2025 to 2025
$1.1M
Impact of Obesity on Chemotherapy-Induced Cytotoxicity: Immune Cells and Skeletal MuscleR00CA276891 · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$249k
Microbiome-Mitochondrial Interactions Driving Cancer-Induced Cachexia in the Obese StateF99CA294251 · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · 2025 to 2025
$39k
HHS | National Institutes of Health (NIH) S10OD032271HHS | NIH | National Cancer Institute (NCI) F31CA278490HHS | NIH | National Cancer Institute (NCI) F99CA294251HHS | NIH | National Cancer Institute (NCI) K99CA276891HHS | NIH | National Cancer Institute (NCI) U01CA272977NCI NIH HHS F31 CA278490NCI NIH HHS F99 CA294251NCI NIH HHS K99 CA276891NCI NIH HHS R00 CA276891NCI NIH HHS U01 CA272977NIH HHS S10 OD032271
6 · The paper itself

Abstract

Cachexia, the loss of skeletal muscle mass and function with cancer, contributes to reduced life quality and worsened survival. Skeletal muscle fibrosis leads to disproportionate muscle weakness; however, the role of infiltrating immune cells and fibro-adipogenic progenitors (FAPs) in cancer-induced muscle fibrosis is not well understood. Using the colon-26 adenocarcinoma (C26) model of cancer cachexia, we sought to examine the changes to skeletal muscle immune cells and FAPs, which contribute to excessive extracellular matrix (ECM) collagen deposition. CD2F1 male mice (

Indexed as

AdipogenesisCachexiaColonic NeoplasmsExtracellular MatrixMuscle, SkeletalAnimalsFibrosisMacrophagesMaleMiceatrophyFAPsmacrophagesmuscle wastingweakness

Identifiers

PMID40929182
PMCPMC12516515

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.